Vivakor Secures Forbearance on $5.94M Loan Amidst Nasdaq Delisting Threat

summarizeSummary

Vivakor entered a forbearance agreement for a $5.94 million defaulted loan, extending maturity but imposing strict repayment terms and a critical Nasdaq reinstatement deadline, highlighting severe financial distress.

check_boxKey Events

• Forbearance Agreement on Major Debt

  Vivakor secured a forbearance agreement for a $5.94 million junior secured convertible promissory note with J.J. Astor & Co., extending the maturity date to January 1, 2027, following a prior default.

• Strict Repayment Schedule with Dilution Potential

  The company agreed to a weekly repayment schedule starting April 6, 2026, with increasing installments, and has the option to pay in common stock under specific, potentially highly dilutive, conditions (e.g., VWAP of at least $1.00).

• Critical Nasdaq Reinstatement Deadline

  A key condition requires Vivakor to regain compliance with Nasdaq listing rules and be reinstated for trading by February 28, 2026, or April 30, 2026, if a reverse stock split application is pending.

• Severe Penalties for Non-Compliance

  Failure to comply with the agreement's terms will result in the outstanding principal increasing by 10%, an interest rate hike to 19% compounded daily, and immediate full repayment.

auto_awesomeAnalysis

This 8-K details a critical forbearance agreement for Vivakor, Inc. on a substantial $5.94 million convertible note, following a prior default. The agreement provides a temporary reprieve by extending the maturity date and reducing the interest rate, but imposes strict weekly repayment terms that can be satisfied with highly dilutive common stock if certain conditions are met. Crucially, the company must achieve Nasdaq reinstatement by late February or April 2026, with a reverse stock split being a potential path. Failure to meet these terms will result in a significant penalty, including an increased principal and higher interest, making the company's financial position even more precarious. This filing underscores the company's severe financial distress and ongoing struggle for survival and continued listing.